Photothera photothera.com


Public lists: Pharma Startups (4732)

Photothere is developing a therapy called NeuroThera, for the treatment of ischemic stroke.

Photothere is developing a therapy called NeuroThera, for the treatment of ischemic stroke.

Company (Alive / Active)

Phone: 760-496-3700

Fax:

2260 Rutherford Road
Suite 101
Carlsbad, 92008
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Photothera $101M Apr 14, 2009
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Photothera Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors

Intarcia Therapeutics

Boston, Massachusetts, United States
Alive / ActiveIntarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enhancing efficacy and reducing the burden therapies often place on the patient's life. Intarcia's drug development expertise and competitive edge is demonstrated by its ability to stabilize macromolecules and to deliver them in a constant and consistent...Show allLogin to see details

Syndax Pharmaceuticals

Waltham, Massachusetts, United States
IPO / Went publicSyndax is a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with an initial focus on tumors that have shown sensitivity to immunotherapy, including lung cancer, melanoma and triple negative breast cancer. Entinostat is an oral, small molecule drug candidate that has direct effects on both cancer cells and immune regulatory cells, potentially enhancing the body's immune response to tumors. Entinostat is being evaluated in a Ph...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Single use lens assembly Nov 02, 2010 Apr 03, 2012 Patent
Low level light therapy for enhancement of neurologic function May 04, 2009 Sep 27, 2011 Patent
Single-use lens assembly Sep 18, 2008 Dec 07, 2010 Patent
Light-emitting device and method for providing phototherapy to the brain Mar 21, 2006 Aug 18, 2009 Patent
Low level light therapy for enhancement of neurologic function Jan 26, 2004 May 19, 2009 Patent